Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market Size, Share, Trends, By Technology, By Tools, By Application, By End-use, and By Region Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
According to a new report, the Synthetic Biology Market size was valued at USD 9.26 Billion in 2021 and is estimated to exceed USD 75.9 Billion in terms of revenue, at a CAGR of 26.3% through 2030. Synthetic biology is an emerging field of science that deals with the design and construction of artificial biological systems for various applications. The market for synthetic biology is expected to grow at a rapid pace owing to the increasing demand for synthetic genes, proteins, and other biomolecules in the pharmaceutical and biotechnology industries.
Products produced by synthetic biology are used in pharmaceutical and biotechnology research, as well as industrial applications. Increasing government funding for synthetic biology research and the ever-expanding application areas of synthetic biology are the major drivers of this market.
Synthetic biology has a potential in DNA sequencing, genetic engineering, and other biotechnology applications. It is anticipated that the demand for synthetic biology will rise in the pharmaceutical and biotech industries for the development of new therapeutic proteins and designer microbes.
Increased amount of study data generation with dipping prices of DNA sequencing, rise in government funding and initiatives, and need for efficient disease management are the prominent drivers of the synthetic biology market. In addition, new applications in healthcare and pharmaceutical industry is another significant factor that is anticipated to fuel the growth of this market during the forecast period.
Rapid Technological Advancements in the Field of Synthetic Biology
Diverse Range of Synthetic Biology-Based Applications Leading to Widespread Adoption in the Biotechnology and Pharmaceutical Industries
Rising Investments Toward Research & Development (R&D) Activities for Synthetic Biology-Based Research
Potential Biosafety, Biosecurity, and Ethical Issues Related to the Unintended or Deliberate Misuse of Synthetic Biology Techniques
Stringent Government Regulations & Guidelines
Technology Outlook (Revenue, USD Billion; 2019-2030)
Nucleotide synthesis and sequencing
Tools Outlook (Revenue, USD Billion; 2019-2030)
Synthetic DNA and Oligonucleotides
Application Outlook (Revenue, USD Billion; 2019-2030)
Medical & Healthcare Application
Artificial Tissue & Tissue Regeneration
Environment & Agriculture
End-use Outlook (Revenue, USD Billion; 2019-2030)
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutions
Regional Outlook (Revenue, USD Billion; 2019-2030)
Rest of Europe
Rest of APAC
Rest of LATAM
Middle East & Africa
Rest of MEA
Key Topics Covered:
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 3. Indicative Metrics
Chapter 4. Synthetic Biology Market Segmentation & Impact Analysis
Chapter 5. Synthetic Biology Market By Technology Insights & Trends
Chapter 6. Synthetic Biology Market By Tools Insights & Trends
Chapter 7. Synthetic Biology Market By Application Insights & Trends
Chapter 8. Synthetic Biology Market By End-use Insights & Trends
Chapter 9. Synthetic Biology Market Regional Outlook
Chapter 10. Competitive Landscape
Chapter 11. Company Profiles
Codex DNA Inc.
Eurofins Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/emcsuf
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900